U.S. Semiconductors Stock News

Framing Solventum after recent share price moves Solventum (SOLV) has come under pressure recently, with the share price weaker over the past week, month, and past 3 months. This has prompted investors to reassess how the healthcare group’s fundamentals line up with current market pricing. See our latest analysis for Solventum. At a current share price of US$62.76, Solventum’s recent 1 month share price return of 15.42% and year to date share price return of 20.58% suggest momentum has been...

We'd be surprised if Datavault AI Inc. ( NASDAQ:DVLT ) shareholders haven't noticed that the Chairman & CFO, Brett...

Today is shaping up negative for LENZ Therapeutics, Inc. ( NASDAQ:LENZ ) shareholders, with the analysts delivering a...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Tron ( NASDAQ:TRON...

We wouldn't blame TMC the metals company Inc. ( NASDAQ:TMC ) shareholders if they were a little worried about the fact...

Middleby has appointed Brittany Cerwin as its new Chief Financial Officer to lead the finance function during a major portfolio transformation. Outgoing CFO Bryan Mittelman will transition to a Special Advisor role and focus on the planned spin off of Middleby’s Food Processing business. The leadership change comes as Middleby prepares to position itself as a more focused commercial foodservice company. For investors watching NasdaqGS:MIDD, this leadership shift lands after a challenging...

If you are wondering whether J. M. Smucker is starting to look attractively priced or still has room to fall, the recent share moves invite a closer look at what you are really paying for. The stock last closed at US$95.24, with returns of 4.2% decline over 7 days, 17.9% decline over 30 days, 1.4% decline year to date, 14.8% decline over 1 year, 32.4% decline over 3 years, and 10.8% decline over 5 years. Recent coverage has focused on how sentiment around packaged foods companies is...

Earlier this month, National Health Investors, Inc. filed an omnibus shelf registration covering common and preferred stock, debt securities, warrants, and units, and announced a US$500 million at-the-market follow-on common equity offering structured through an income trust. This combination of a sizable equity program and broad shelf capacity increases the REIT’s funding options and may influence how it balances growth investments with potential dilution and balance sheet...

Insider selling raises questions around Agnico Eagle Mines (AEM) Recent filings show heavy insider selling at Agnico Eagle Mines (AEM), including US$16m of disposals over the past quarter and an US$8m sale by the CEO, with no offsetting insider purchases reported. See our latest analysis for Agnico Eagle Mines. Against this insider activity, Agnico Eagle Mines’ recent share price moves have been mixed, with a 7.97% 7 day share price return and a 23.13% 30 day share price decline. However, a...

BlackLine (BL) has just expanded its share repurchase authorization by US$100 million to US$500 million and added two directors, moves that frame how management is thinking about capital allocation and future execution. See our latest analysis for BlackLine. BlackLine’s share price has been under pressure, with a 1-day share price return showing a 4.02% decline and a 7-day share price return showing a 7.82% decline. The 1-year total shareholder return shows a 26.14% decline, indicating that...

In March 2026, Evolv Technologies Holdings, Inc. announced that the Houston Astros had renewed and expanded their subscription agreement, upgrading Daikin Park to Evolv Express Gen2 systems and adding eXpedite bag-screening units for stadium staff across the 41,000-seat venue. This renewal not only makes Daikin Park the first professional baseball stadium to deploy eXpedite but also reinforces Evolv’s footprint across the Houston major league sports market and contributes to its roster of...

Why JPMorgan’s upgrade is drawing attention to Air Products and Chemicals (APD) JPMorgan’s recent upgrade of Air Products and Chemicals (APD), tied to stable earnings and helium market support, has pushed the stock onto more investors’ radars, particularly among those monitoring industrial gases and energy related demand. See our latest analysis for Air Products and Chemicals. The recent upgrade comes after a period of building momentum, with a 90 day share price return of 17.89% and a year...

Best Buy stock performance snapshot Best Buy (BBY) has seen mixed share performance, with the price down about 9% year to date and 8% over the past year, while the past month shows a modest positive return. See our latest analysis for Best Buy. The recent 1 month share price return of 1.63% contrasts with a weaker 3 month share price return of a 7.16% decline and a 1 year total shareholder return of an 8.17% decline, suggesting momentum has been fading rather than building. If you are...

Some Universal Insurance Holdings, Inc. ( NYSE:UVE ) shareholders may be a little concerned to see that the Executive...

NRx Pharmaceuticals, Inc. ( NASDAQ:NRXP ) is possibly approaching a major achievement in its business, so we would like...

A shareholder proposal seeks to cap executive severance at Capital One Financial (NYSE:COF) at 2.99 times base salary plus target bonus. The proposal would require shareholder approval for any senior manager pay package that exceeds this threshold. Capital One has filed a definitive proxy statement recommending that shareholders vote against the proposal at its May annual meeting. Capital One Financial, the parent of Capital One Bank, operates across credit cards, consumer lending, and...

Wondering whether Curtiss-Wright at around US$663 per share still offers value, or if most of the opportunity has already been priced in. The stock has recorded a 1 year return of 109.8% and a 3 year return of 279.6%. In contrast, the 7 day and 30 day returns of a 1.1% decline and a 5.3% decline hint at some recent cooling after a strong run. Over 5 years, Curtiss-Wright has delivered a very large total return of 463.7%. This naturally raises questions about what is now embedded in the...

If you are trying to figure out whether CRISPR Therapeutics is attractively priced or not, the recent share performance gives you a lot to think about. The stock last closed at US$45.75, with a 1.1% decline over 7 days, a 23.9% decline over 30 days, a 14.9% decline year to date, but a 23.7% gain over 1 year and a 1.1% gain over 3 years compared to a 61.7% decline over 5 years. These shifts in returns have kept CRISPR Therapeutics on many watchlists, as investors weigh shorter term weakness...

In March 2026, global talent solutions and consulting firm Robert Half was named by Fortune as one of America's Most Innovative Companies, highlighting its AI-powered tools and proprietary data-driven capabilities in improving talent matching and client support. This innovation recognition comes as Robert Half continues to contend with declining sales and earnings, underscoring a tension between its technology progress and current business headwinds. Now we will examine how this innovation...

If you are wondering whether Greif is offering fair value at its recent price, this breakdown will help you see how the current share level stacks up against several valuation checks. The stock recently closed at US$66.37, with a 6.0% return over the past 7 days, an 8.7% decline over 30 days, a 3.0% decline year to date, and a 25.2% gain over the past year, which may influence how you think about both upside potential and risk. Those swings sit alongside a longer track record, with returns...

Recent price action and business context Legence (LGN) has drawn fresh attention after a recent share price move, with the stock closing at US$54.75 and showing mixed short term returns over the past week, month and past 3 months. For readers tracking the underlying business, Legence reports US$2.55b in revenue across engineering, installation and maintenance services for mission critical building systems in the United States. These operations are supported by two segments: Engineering &...

If you are wondering whether e.l.f. Beauty at around US$61.05 is a bargain or already pricing in a lot of optimism, this breakdown will help you frame that question clearly. The share price has recently been under pressure, with a 15.8% decline over 7 days, a 33.7% decline over 30 days, and a 21.5% decline year to date, compared with a 5.8% decline over the last year and a 25.9% decline over 3 years. These moves come as investors continue to reassess the broader beauty and personal care...

If you are wondering whether Arista Networks' current share price lines up with its underlying value, you are not alone. This article walks through what the numbers actually say. The stock trades at US$120.77 after a 7 day return of an 8% decline and a 30 day return of a 9.5% decline, set against a 1 year return of 55% and a very large 5 year gain. Recent attention has focused on Arista Networks as investors weigh its role in networking and cloud infrastructure. Headlines frequently link the...

Recent performance snapshot Karman Holdings (KRMN) has drawn investor attention after a past year total return of about 140%, alongside a decline of nearly 5% over the past month and a gain of roughly 8% over the past three months. See our latest analysis for Karman Holdings. With the share price at $84.07, Karman Holdings has seen short term pressure, including a 15.4% decline in the 7 day share price return, while its 1 year total shareholder return of about 140% still signals strong longer...